There were 79 press releases posted in the last 24 hours and 400,484 in the last 365 days.

BTI INVESTORS: Lead Plaintiff Deadline Quickly Approaching; Contact Robbins LLP for Information About Your Rights

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired British American Tobacco P.L.C. (NYSE: BTI) securities between February 9, 2023 and December 6, 2023. British American Tobacco is a multi-national tobacco company that sells cigarettes (which the Company refers to in its filings as “combustibles” or “sticks”, for individual cigarettes) and other tobacco-related products, such as vaping products, chewing tobacco, snus, and heated tobacco products.

For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is this Case About: American British Tobacco P.L.C. (BTI) Allegedly Failed to Disclose the Risks and Potential Likelihood of an Impairment to its Premium American Cigarette Brands

According to the complaint, during the class period, defendants failed to disclose that British American Tobacco materially understated the risks and potential likelihood of an impairment to its Premium American Cigarette Brands as a result of various longstanding headwinds.

In January 2017, British American Tobacco, which already had a 42% stake in Reynolds American Inc. (“Reynolds”), took over the remaining interest in Reynolds for $49.4 billion dollars, valuing Reynolds at around $86 billion. Reynolds became a subsidiary and British American Tobacco took control of the Camel, Newport, and Natural American Spirit cigarette brands ("Premium American Cigarette Brands"), among others.

On December 6, 2023, British American Tobacco issued a press release announcing that it was taking a 25 billion Pound (or around $31.5 billion USD) impairment on the cigarette brands it acquired from Reynolds. On this news, British American’s ADR price fell $2.68 per share, or 8.88%, to close at $28.86 per ADR on December 6, 2023.

What Now: Similarly situated shareholders may be eligible to participate in the class action against British American Tobacco P.L.C. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. Plaintiffs must file their lead plaintiff papers by March 25, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.  

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against British American Tobacco, P.L.C. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contact:
Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com
https://www.facebook.com/RobbinsLLP/
https://www.linkedin.com/company/robbins-llp/

 


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.